Company news

Proteomics International Laboratories Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Proteomics International seeks FDA approval for PromarkerD

February 7, 2021

December 2020 Quarterly Activities Report and Appendix 4C

January 27, 2021

AGM Investor Presentation

November 25, 2020

Middle East is next market for PromarkerD immunoassay test

November 11, 2020

PromarkerD clinical assay performance results published

November 4, 2020

Proteomics receives $1.1 million in R&D tax incentive

November 2, 2020

Completion of Placement and Appendix 2A

November 1, 2020

September 2020 Quarterly Activities Report and Appendix 4C

October 27, 2020

Proteomics International raises $6m in successful Placement

October 22, 2020

First distribution agreement for PromarkerD immunoassay

October 15, 2020

Partnership with QIMR Berghofer targets oesophageal cancer

October 8, 2020

June 2020 Quarterly Activities Report and Appendix 4C

July 28, 2020

PromarkerD Intellectual Property portfolio expands

July 27, 2020

Appendix 3Y - Directors on-market purchase of shares

June 28, 2020

Big pharma clinical study validates PromarkerD kidney test

June 14, 2020

Updated Investor Presentation

June 9, 2020

Proteomics International receives COVID-19 research grants

May 25, 2020

Appendix 4C and Quarterly Report - March 2020

April 27, 2020

CE Mark for Proteomics PromarkerD Immunoassay Kit

April 15, 2020

Proteomics expands diagnostics R&D - the Promarker Pipeline

April 7, 2020

Proteomics International expands study with US big pharma

March 30, 2020

Proteomics patents biomarkers for diagnosis of endometriosis

March 22, 2020

Appendix 4C - December 2019 Quarterly Report

January 28, 2020

CE Mark for PromarkerD Hub predictive software for DKD

January 13, 2020

Partnership provides funding for cutting-edge facility

November 25, 2019

Proteomics raises $3m in heavily oversubscribed Placement

November 14, 2019

CE Mark for predictive test for diabetic kidney disease

November 11, 2019

Appendix 4C - September 2019 Quarterly Report

October 30, 2019

PromarkerD IVD successfully developed and validated

September 17, 2019

PromarkerD diabetic kidney disease test launched in Spain

September 13, 2019

PromarkerD test ready for launch in Europe

September 12, 2019

Appendix 4C - June 2019 Quarterly Report

July 30, 2019

Proteomics secures contracts for pharmacokinetic analysis

July 25, 2019

Appendix 4C - March 2019 Quarterly Report

April 23, 2019

US patent for identifying drugs for abnormal kidney function

February 20, 2019

Appendix 4C - December 2018 Quarterly Report

January 29, 2019

PromarkerD US market update

January 23, 2019

Proteomics signs PromarkerD agreement with US big pharma

November 25, 2018

PromarkerD kit version complete- commercial release imminent

November 8, 2018

Appendix 4C - September 2018 Quarterly Report

October 29, 2018

Diabetic kidney disease test enters Europe & Export Award

October 23, 2018

Proteomics receives $834k in R&D Tax Incentive

October 16, 2018

Proteomics & Atturos partner to target diagnostics in Europe

September 19, 2018

Proteomics to receive $928k from sale of shareholding in CPR

September 12, 2018

Diagnostics update- Pipeline yields potential new biomarkers

August 22, 2018

Appendix 4C - June 2018 Quarterly Report

July 29, 2018

Proteomics secures major contract - nears cash flow positive

July 18, 2018

Further information on new licence deals in USA and Mexico

June 20, 2018

Proteomics signs deal with Patia for PromarkerD in Mexico

June 17, 2018

Proteomics signs deal to launch PromarkerD test in US market

May 28, 2018

← Newer news releases · Older news releases →

Decks

The 5 newest of 46 decks. Every deck is listed under its year.